By Maria Ruiz, RD · Reviewed by Dr. Elena Santos, MD · Last reviewed: May 15, 2026
GLP-1 and Alcohol: What the FDA Labels Actually Say
Wine at dinner. A beer at the game. One drink at a friend's wedding. What changes on Wegovy, Ozempic, Zepbound, or Mounjaro? Here is what the FDA labels, the Novo Nordisk and Eli Lilly patient guides, and the National Institute on Alcohol Abuse and Alcoholism say.
The short answer:
- • No direct drug interaction listed on any FDA label
- • Alcohol compounds GI side effects (nausea, reflux)
- • Hypoglycemia risk is higher if you also take insulin or a sulfonylurea
- • Many users report a sharp drop in alcohol cravings (NIH is studying this)
- • Talk with your prescriber if you drink regularly
Alcohol Interactions by Drug
| Drug | Direct interaction? | Hypoglycemia risk | GI compounding |
|---|---|---|---|
| Wegovy (semaglutide) | No | Low (unless on insulin) | High |
| Ozempic (semaglutide) | No | Higher (T2D + insulin or sulfonylurea) | High |
| Zepbound (tirzepatide) | No | Low (unless on insulin) | Moderate to high |
| Mounjaro (tirzepatide) | No | Higher (T2D + insulin or sulfonylurea) | Moderate to high |
Source: FDA Prescribing Information for Wegovy, Ozempic, Zepbound, and Mounjaro. T2D refers to type 2 diabetes patients.
Why Alcohol Feels Stronger on a GLP-1
GLP-1 drugs slow stomach emptying. Food sits longer. So does alcohol. That changes three things:
- 1. Alcohol absorbs more slowly, then hits all at once
- 2. Stomach irritation lasts longer (reflux, nausea, burping)
- 3. Hangovers tend to feel rougher even at lower amounts
The Novo Nordisk patient guide for Wegovy and Ozempic suggests caution with alcohol. The Eli Lilly patient guide for Zepbound and Mounjaro says the same. Neither sets a hard limit. Use common sense and check with your prescriber if you drink regularly.
Hypoglycemia Risk: The Real Concern
For people taking a GLP-1 alone (no insulin, no sulfonylurea), low blood sugar from alcohol is uncommon. The risk goes up in two cases:
- • You take insulin alongside your GLP-1 (often T2D patients)
- • You take a sulfonylurea (glipizide, glyburide, glimepiride)
The FDA labels for Ozempic and Mounjaro both flag this. Alcohol blocks the liver from releasing glucose. Combined with insulin or a sulfonylurea pushing blood sugar down, this can drop you fast. Signs of low blood sugar:
- • Shakiness, sweating, fast heartbeat
- • Confusion, slurred speech
- • Hunger, headache, dizziness
- • Vision changes, weakness
If you take insulin or a sulfonylurea and you plan to drink, eat protein first, sip a glucose-containing mixer for the first drink, and check your blood sugar before bed. Carry glucose tablets. Wear a CGM if you have one.
Published Research: GLP-1 and Alcohol Cravings
A growing body of published research suggests that semaglutide and other GLP-1 drugs reduce alcohol craving. This is research, not clinical guidance. Here is what is in the public record.
- • The National Institute on Alcohol Abuse and Alcoholism (NIAAA) has funded multiple GLP-1 trials
- • A 2024 study published in JAMA Psychiatry found semaglutide cut drinking days in patients with alcohol use disorder
- • Earlier animal studies at the University of North Carolina showed reduced alcohol intake on semaglutide
- • The NIH is funding a phase 2 trial to study GLP-1 for alcohol use disorder
No GLP-1 is FDA-approved for alcohol use disorder. Talk with your prescriber or an addiction medicine specialist if you want to explore this. We are quoting published findings only.
Practical Tips If You Drink on a GLP-1
- • Eat a protein-rich snack first (cheese, nuts, jerky, hummus)
- • Pick dry wines or clear spirits with low-sugar mixers
- • Sip water between every drink
- • Skip sweet cocktails, dessert wines, and sangria
- • Plan a slow night, not a session
- • Skip drinking on shot day (nausea peaks then)
- • Tell your prescriber the truth about how much you drink
Related guides
- Full drug and food interactions guide - alcohol plus 9 more interactions
- Side effects management - nausea, constipation, fatigue
- Full GLP-1 diet guide - food rules for Wegovy, Ozempic, Zepbound, Mounjaro
Frequently Asked Questions
Does alcohol interact with GLP-1 drugs?
Per the FDA labels for Wegovy, Ozempic, Zepbound, and Mounjaro, alcohol is not listed as a direct drug interaction. Alcohol does not change how semaglutide or tirzepatide work in the bloodstream. The real issue is that alcohol compounds the GI side effects (nausea, vomiting, reflux) and raises the risk of low blood sugar when used alongside certain diabetes medications.
Why do I feel sick after one drink on Wegovy?
GLP-1 drugs slow stomach emptying. Alcohol also slows stomach emptying and irritates the gut lining. The two stack. Many users report that one or two drinks now feels like four or five. Nausea, reflux, and a hangover-like feeling can hit faster and last longer. The Novo Nordisk patient guide suggests caution with alcohol.
Can alcohol cause low blood sugar on a GLP-1?
Yes, but mostly for T2D patients on combination therapy. The FDA labels for Ozempic and Mounjaro warn that hypoglycemia risk goes up when these drugs are used with insulin or a sulfonylurea (glipizide, glyburide, glimepiride). Alcohol then makes the risk even higher because it blocks the liver from releasing glucose. For non-diabetic Wegovy or Zepbound users, the hypoglycemia risk from alcohol alone is low.
What is the NIH research on GLP-1 and alcohol cravings?
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) and several university research groups are studying GLP-1 receptor agonists for alcohol use disorder. Published findings in 2023 and 2024 show that semaglutide and similar drugs cut alcohol craving in animal models and in early human trials. No GLP-1 is currently FDA-approved for alcohol use disorder. This is published research, not a clinical recommendation. Talk with your prescriber if you struggle with alcohol.
How much alcohol is safe on Wegovy or Ozempic?
Neither Novo Nordisk nor the FDA gives a specific limit. The general advice from the patient guides is to use caution and talk with your prescriber. The CDC guideline of up to 1 drink per day for women and 2 for men still applies. Many GLP-1 users naturally drop well below that because the drug reduces the urge to drink. If you feel sick on one drink, your body is telling you to stop.
Can I drink wine on a GLP-1?
Wine is allowed. The FDA labels do not flag wine differently from other alcohol. Dry wines (Sauvignon Blanc, Pinot Grigio, Chardonnay, dry reds) have less sugar than sweet wines or cocktails. Lower sugar means less spike in nausea. Sip slowly and eat a small protein-rich snack first. Skip dessert wines and sangria because the sugar load compounds GI side effects.
Do GLP-1 drugs work for alcohol use disorder?
Not yet officially. The NIAAA has funded multiple trials of semaglutide and other GLP-1 drugs for alcohol use disorder. Published 2024 results in trade journals showed reduced cravings and reduced drinking in some patient groups. The FDA has not approved any GLP-1 for this use as of 2026. If you want to explore this, your prescriber can discuss off-label options or refer you to an addiction medicine specialist.
Should I stop my GLP-1 before a wedding or a vacation?
There is no medical reason to stop. The FDA labels and both manufacturer guides do not call for a pause around social drinking events. But many users plan ahead by eating a small protein meal before drinking, sticking to lower-sugar drinks, and pacing slower than they used to. Skipping a weekly shot to drink more is not recommended because it disrupts steady drug levels and can raise side effects when you restart.
Primary Sources
- FDA. Wegovy (semaglutide) Prescribing Information. Novo Nordisk.
- FDA. Ozempic (semaglutide) Prescribing Information. Novo Nordisk.
- FDA. Zepbound (tirzepatide) Prescribing Information. Eli Lilly.
- FDA. Mounjaro (tirzepatide) Prescribing Information. Eli Lilly.
- Novo Nordisk Patient Information Guide for Wegovy and Ozempic.
- Eli Lilly Patient Information Guide for Zepbound and Mounjaro.
- National Institute on Alcohol Abuse and Alcoholism (NIAAA). Research on Pharmacotherapy for Alcohol Use Disorder.
- JAMA Psychiatry. 2024. Studies on Semaglutide and Alcohol Use Disorder.
- Centers for Disease Control and Prevention. Dietary Guidelines for Alcohol.